CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 454.0	$ 438.7
Accounts receivable, net	295.0	307.6
Inventories	620.5	589.8
Other current assets	107.2	95.8
Total current assets	1,476.7	1,431.9
Property, plant and equipment, net	296.7	299.5
Intangibles, net and other long-term assets	254.3	256.9
Total assets	2,027.7	1,988.3
Current liabilities:
Current portion of long-term debt	0.7	0.7
Accounts payable	116.4	74.8
Customer advances	251.2	258.6
Other current liabilities	302.8	314.5
Total current liabilities	671.1	648.6
Long-term debt	354.1	354.3
Other long-term liabilities	134.2	135.2
Commitments and contingencies (Note 10)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 167,910,179 and 167,619,039 shares issued and 167,869,822 and 167,579,204 shares outstanding at March 31, 2014 and December 31, 2013, respectively	1.7	1.7
Treasury stock, at cost, 40,357 and 39,835 shares at March 31, 2014 and December 31, 2013, respectively	(0.6)	(0.6)
Accumulated other comprehensive income	185.2	182.4
Other shareholders' equity	676.3	662.6
Total shareholders' equity attributable to Bruker Corporation	862.6	846.1
Noncontrolling interest in consolidated subsidiaries	5.7	4.1
Total shareholders' equity	868.3	850.2
Total liabilities and shareholders' equity	$ 2,027.7	$ 1,988.3